-
Biomimetic Chromatography for Lung Permeability
2026-08-18
Dillon and colleagues evaluated mass spectrometry-compatible immobilised artificial membrane liquid chromatography and open-tubular capillary electrochromatography as biomimetic models of pulmonary drug permeability. Their results show that IAM-LC can reproduce important permeability relationships, while OT-CEC adds complementary information about phospholipid-dependent drug–membrane interactions.
-
Low-Cost Microfluidic Mixers for mRNA LNP Research
2026-08-18
Forrester and colleagues compare two low-cost microfluidic mixers with pipette mixing for lipid nanoparticle production, combining physicochemical characterization with expression studies. Their results indicate that accessible mixing approaches can support formulation screening and produce LNPs with useful size, encapsulation, and expression profiles, while also highlighting the need for orthogonal quality assessment.
-
Nonivamide: A TRPV1 Assay Decision Framework
2026-08-17
Nonivamide is a capsaicin analog that connects TRPV1 pharmacology with cancer cell growth inhibition and neuroimmune assay design. This guide focuses on selecting the right biological scale, controls, readouts, and interpretation strategy rather than repeating a conventional product overview.
-
Realgar CNS Toxicity and the Liver–Brain Axis
2026-08-17
The reference study identifies a liver–brain mechanism in which realgar-derived arsenic and OTC-linked ornithine accumulation converge on ZBTB7A-dependent suppression of astrocyte glycolysis. Its integrated animal, cellular, transcriptomic, metabolomic, behavioral, and histopathological design provides a framework for studying how hepatic nitrogen metabolism can influence CNS energy failure during toxicant exposure.
-
Cap 1 Firefly mRNA for Translation Insight
2026-08-16
Cap 1 architecture and an optimized poly(A) tail make firefly luciferase mRNA more than a light-producing reagent: they create a practical instrument for separating delivery, stability, translation, and biological response. This thought-leadership guide connects EZ Cap™ Firefly Luciferase mRNA with formulation science, assay design, and translational decision-making.
-
Pseudo-UTP: From Nucleotide to Vaccine Design
2026-08-15
Pseudo-modified uridine triphosphate can reshape how researchers evaluate RNA performance, from in vitro transcription to immune function. This article presents a systems-level framework for using Pseudo-UTP in mRNA vaccine development, gene therapy RNA modification, and assay design.
-
Vidarabine monohydrate: Antiviral Workflow Guide
2026-08-14
Build more reliable DNA-virus assays with Vidarabine monohydrate by controlling DMSO formulation, exposure timing, and orthogonal replication readouts. This guide translates a high-content interaction-screening strategy into practical antiviral experiments without overstating evidence across research domains.
-
Schisandra Decoction in a Mouse Parkinson’s Model
2026-08-14
This study links Schisandra Decoction treatment with improved motor behavior, preservation of tyrosine hydroxylase, and reduced α-synuclein abundance in MPTP-induced Parkinson’s disease mice. Its main contribution is an integrated examination of the PTEN–PI3K/AKT/mTOR axis and autophagy-related markers, while also highlighting important limits on causal and clinical interpretation.
-
LC-MS/MS Metabolomics of Carbapenemase Resistance
2026-08-13
The reference study shows that LC-MS/MS metabolomics can distinguish carbapenemase-producing Enterobacterales from non-CPE isolates using antibiotic-free cultures and machine-learning analysis. Its 21 metabolite biomarkers provide both a potential rapid diagnostic foundation and mechanistic clues involving transport, nucleotide, arginine, biotin, and biofilm-related metabolism.
-
Cy5-UTP: From RNA Labeling to STAU2 Biology
2026-08-13
A translational strategy for using Cy5-UTP and Cyanine 5-uridine triphosphate to connect RNA probe synthesis with STAU2 condensate biology, neuronal RNA transport, and activity-dependent translation.
-
Western Secondary Antibody Dilution Buffer for NHE1 Blots
2026-08-12
Improve protein detection in macrophage and plaque Western blots with a secondary antibody diluent formulated for lower background and more stable working solutions. This workflow connects NHE1–Olfr2 atherosclerosis biology with practical assay controls, reuse planning, and troubleshooting.
-
L-Ornithine in Urea Cycle Research
2026-08-12
L-Ornithine enables controlled studies of OTC activity, nitrogen disposal, and liver–brain metabolic signaling without relying on poorly defined metabolic perturbations. This workflow-oriented guide connects reagent preparation with enzyme assays, astrocyte models, and troubleshooting strategies inspired by recent CNS toxicity research.
-
β-Amanitin for Reliable Transcription Assays
2026-08-11
Learn how β-Amanitin (SKU B8467) can support controlled RNA polymerase II inhibition, transcriptional regulation research, and interpretation of cell viability data. The article combines practical assay design, handling parameters, toxicology context, and evidence-based product selection.
-
Kanamycin Sulfate: Selection Workflows & Troubleshooting
2026-08-11
Kanamycin Sulfate supports reproducible bacterial selection, broth-dilution assays, and antibiotic resistance research without requiring ethanol or DMSO as a solvent. This practical guide connects a classic aminoglycoside susceptibility study with modern microbiology workflows, including assay design, controls, and troubleshooting.
-
LDN-193189 Workflows for BMP Research
2026-08-10
LDN-193189 enables selective ALK2/ALK3 interrogation in BMP-driven cell models, from corneal epithelial expansion to pathway-focused barrier assays. This guide translates the reference study’s six-component culture system into practical dosing, controls, troubleshooting, and follow-up experiments.